DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹1,461 Cr | ₹1,156 Cr | ₹794 Cr | ₹715 Cr | ₹1,509 Cr |
What is the latest Short Term Loans and Advances ratio of DIVIS LABORATORIES ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2026 | ₹1,461 Cr |
| Mar2025 | ₹1,156 Cr |
| Mar2024 | ₹794 Cr |
| Mar2023 | ₹715 Cr |
| Mar2022 | ₹1,509 Cr |
How is Short Term Loans and Advances of DIVIS LABORATORIES Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,461 Cr | 26.38 | |
| Mar2025 | ₹1,156 Cr | 45.59 | |
| Mar2024 | ₹794 Cr | 11.05 | |
| Mar2023 | ₹715 Cr | -52.63 | |
| Mar2022 | ₹1,509 Cr | - | |
Compare Short Term Loans and Advances of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹244,601.2 Cr | -3.3% | -0.2% | 63.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,562.0 Cr | -3.2% | -7.8% | 14.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,871.0 Cr | -2.4% | -5% | 33.6% | Stock Analytics | |
| CIPLA | ₹107,770.0 Cr | -4% | -5.6% | -10.2% | Stock Analytics | |
| MANKIND PHARMA | ₹102,433.0 Cr | 1.7% | 4.2% | 1.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,829.0 Cr | -1.2% | 4.1% | -4.2% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -3.3% |
-0.2% |
63.3% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses